Skip to main content
    • Aa
    • Aa

Emerging roles of pathogens in Alzheimer disease

  • Judith Miklossy (a1)

Chronic spirochetal infection can cause slowly progressive dementia, cortical atrophy and amyloid deposition in the atrophic form of general paresis. There is a significant association between Alzheimer disease (AD) and various types of spirochete (including the periodontal pathogen Treponemas and Borrelia burgdorferi), and other pathogens such as Chlamydophyla pneumoniae and herpes simplex virus type-1 (HSV-1). Exposure of mammalian neuronal and glial cells and organotypic cultures to spirochetes reproduces the biological and pathological hallmarks of AD. Senile-plaque-like beta amyloid (Aβ) deposits are also observed in mice following inhalation of C. pneumoniae in vivo, and Aβ accumulation and phosphorylation of tau is induced in neurons by HSV-1 in vitro and in vivo. Specific bacterial ligands, and bacterial and viral DNA and RNA all increase the expression of proinflammatory molecules, which activates the innate and adaptive immune systems. Evasion of pathogens from destruction by the host immune reactions leads to persistent infection, chronic inflammation, neuronal destruction and Aβ deposition. Aβ has been shown to be a pore-forming antimicrobial peptide, indicating that Aβ accumulation might be a response to infection. Global attention and action is needed to support this emerging field of research because dementia might be prevented by combined antibiotic, antiviral and anti-inflammatory therapy.

Corresponding author
*Corresponding author: Judith Miklossy, 1921 Martigny-Croix CP 16, 1921, Switzerland. E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2A. Alzheimer (1911) Über eigenartige Krankheitsfälle des späteren Alters. Zeitschrift für die gesamte Neurologie und Psychiatrie 4, 356385

3R. Katzman (1976) The prevalence and malignancy of Alzheimer's disease: a major killer. Archives of Neurology 33, 217218

4R.D. Terry and P. Davies (1980) Dementia of the Alzheimer type. Annual Review of Neuroscience 3, 7795

9R.D. Terry (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 30, 572580

10J. Kang (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733736

11D.J. Selkoe (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends in Cell Biology 8, 447453

12G.G. Glenner and C.W. Wong (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications 120, 885890

13D. Schubert (1988) Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. Science 241, 17591763

14A.I. Bush , K. Beyreuther and C.L. Masters (1993) The beta A4 amyloid protein precursor in human circulation. Annals of the New York Academy of Sciences 695, 175182

16J.S. Allen (1991) Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells. Neuroscience Letters 132, 109112

17U. Mönning (1990) Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Letters 277, 261266

19J.T. Jarrett and P.T. Lansbury (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31, 1234512352

20W. Kim and M.H. Hecht (2005) Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40. Journal of Biological Chemistry 280, 3506935076

21M.P. Lambert (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America 95, 64486453

23D.M. Walsh (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535539

24M.D. Kirkitadze , G. Bitan and D.B. Teplow (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. Journal of Neuroscience Research 69, 567577

25E. Cerf (2009) Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta- peptide. Biochemical Journal 421, 415423

26J. Pitt (2009) Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicology and Applied Pharmacology 240, 189197

27H.A. Lashuel (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291

28T. Rudel (1996) Modulation of Neisseria porin (PorB) by cytosolic ATP/GTP of target cells: parallels between pathogen accommodation and mitochondrial endosymbiosis. Cell 85, 391402

29P. Ayala (2005) The pilus and porin of Neisseria gonorrhoeae cooperatively induce Ca(2+) transients in infected epithelial cells. Cellular Microbiology 7, 17361748

30A. Müller (1999) Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO Journal 18, 339352

31S.J. Soscia (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505

32M. Kidd (1963) Paired helical filaments in electron microscopy of Akzheimer's disease. Nature 197, 192193

33R.D. Terry (1963) The fine structure of neurofibrillary tangles in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 22, 629642

35V.M.-Y. Lee (1995) Disruption of the cytoskeleton in Alzheimer's disease. Current Opinion in Neurobiology 5, 663668

36P.J. Lu (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784788

37R. Sherrington (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754760

38D.J. Selkoe (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. Journal of Biological Chemistry 271, 1829518298

39J. Hardy (1997) The Alzheimer family of diseases: many etiologies, one pathogenesis? Proceedings of the National Academy of Sciences of the United States of America 94, 20952097

40R.E. Tanzi and L. Bertram (2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181184

41J. Hardy and D.J. Selkoe (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353356

42L. Bertram and R.E. Tanzi (2005) The genetic epidemiology of neurodegenerative disease. Journal of Clinical Investigation 115, 14491457

43Z. Nagy (2005) The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease. Journal of Cellular and Molecular Medicine 9, 531541

44G.D. Schellenberg (1995) Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proceedings of the National Academy of Sciences of the United States of America 92, 85528559

45A. Goate (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704706

46M. Mullan (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nature Genetics 1, 345347

48W. Wasco (1995) Familial Alzheimer's chromosome 14 mutations. Nature Medicine 1, 848

49J. Perez-Tur (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297301

50J. Miklossy (2003) Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-on set Alzheimer's disease. Neurobiology of Aging 24, 655662

51E. Levy-Lahad (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973977

52M. Citron (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672674

53X.D. Cai , T.E. Golde and S.G. Younkin (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259, 514516

54N. Suzuki (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 13361340

55K. Duff (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710713

56D. Scheuner (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Medicine 2, 864870

57D.R. Borchelt (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 10051013

58T. Tomita (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proceedings of the National Academy of Sciences of the United States of America 94, 20252030

59M. Citron (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Medicine 3, 6772

61P.L. McGeer and E.G. McGeer (2001) Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Archives of Neurology 58, 17901792

62L. Bertram (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics 39, 1723

63J. Guo (2006) A-beta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 103, 19531958

65P. Davies , R. Katzman and R.D. Terry (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 288, 279280

66E.K. Perry (1981) Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiology of Aging 2, 251256

70R.T. Bartus (1985) The cholinergic hypothesis: a historical overview, current perspective, and future directions. Annals of the New York Academy of Sciences 444, 332358

71R.N. Martins (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. Journal of Neurochemistry 46, 10421045

72M.A. Pappolla (1996) The heat shock/oxidative stress connection. Relevance to Alzheimer disease. Molecular and Chemical Neuropathology 28, 2134

73M.A. Smith (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Annals of the New York Academy of Sciences 738, 447454

74A. Nunomura (2006) Involvement of oxidative stress in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 65, 631641

75W.D. Parker Jr. (1991) Cytochrome oxidase deficiency in Alzheimer's disease. Annals of the New York Academy of Sciences 640, 5964

76R.D. Terry and C. Pena (1965) Experimental production of neurofibrillary degeneration: electron microscopy, phosphatase histochemistry and electron probe analysis. Journal of Neuropathology and Experimental Neurology 24, 200210

77D.R. Crapper , S.S. Krishnan and A.J. Dalton (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180, 511513

78K. Jellinger (1990) Brain iron and ferritin in Parkinson's and Alzheimer's diseases. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 2, 327340

79Y.H. Suh (1996) Molecular physiology, biochemistry, and pharmacology of Alzheimer's amyloid precursor protein (APP). Annals of the New York Academy of Sciences 786, 169183

80Z.S. Khachaturian (1994) Calcium hypothesis of Alzheimer's disease and brain aging. Annals of the New York Academy of Sciences 747, 111

81H. Mori , J. Kondo and Y. Ihara (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 16411644

82Y.A. Lam (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 97, 99029906

83J.C. de la Torre and T. Mussivand (1993) Can disturbed brain microcirculation cause Alzheimer's disease? Neurological Research 15, 146153

84M.M. Esiri (1999) Cerebrovascular disease and threshold for dementia in the early stage of Alzheimer's disease. Lancet 354, 919920

85V. Hachinski and D.G. Munoz (1997) Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon? Annals of the New York Academy of Sciences 826, 16

86D.A. Snowdon (1997) Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study. Journal of the American Medical Association 277, 813817

87G.I. De Jong (1997) Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies. Annals of the New York Academy of Sciences 826, 5674

88J.F. Diaz (1991) Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. Archives of Neurology 48, 10221025

89R.N. Kalaria (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiology of Aging 21, 321330

90O.C. Suter (2002) Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 33, 19861992

91J. Miklossy (2003) Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurological Research 25, 605610

93D.L. Sparks (1997) Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Annals of the New York Academy of Sciences 826, 128146

95D.M. Mann , C.M. Tucker and P.O. Yates (1988) Alzheimer's disease: an olfactory connection? Mechanisms of Aging and Development 42, 115

96J.A. Hardy (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiology of Aging 7, 489502

98P.L. McGeer (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neuroscience Letters 79, 195200

99W.S. Griffin (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 86, 76117615

100P.L. McGeer and J. Rogers (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42, 447449

102P.L. McGeer and E.G. McGeer (1995) The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research Reviews 21, 195218

103P.L. McGeer and E.G. McGeer (2002) Local neuroinflammation and the progression of Alzheimer's disease. Journal of Neurovirology 8, 529538

104S. Webster (1997) Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiology of Aging 18, 415421

105W.F. Stewart (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626632

106P.P. Zandi (2000) Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 59, 880886

108H. Akiyama (2000) Inflammation and Alzheimer's disease. Neurobiology of Aging 21, 383421

109O. Fischer (1907) Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatsschrift für Psychiatrie und Neurologie 22, 361372

111Z.S. Khachaturian (1985) Diagnosis of Alzheimer's disease. Archives of Neurology 42, 10971105

112A.H. Hübner (1908) Zur Histopathologie der senilen Hirnrinde. Archives of Psychiatry and Neurology 46, 598609

118J. Miklossy (2008) Biology and neuropathology of dementia in syphilis and Lyme disease. In Dementias, Handbook of Clinical Neurology (C. Duyckaerts and I. Litvan , eds), Vol. 89, pp. 825844, Elsevier, Edinburgh, London

119H. Noguchi and J.W. Moore (1913) A demonstration of Treponema pallidum in the brain of general paralysis cases. Journal of Experimental Medicine 17, 232238

127P. Saikku (1999) Epidemiology of Chlamydia pneumoniae in atherosclerosis. American Heart Journal 138 (Suppl), 500503

128M.A. Mendall (1994) Relation of Helicobacter pylori infection and coronary heart disease. British Heart Journal 71, 437439

129C. Martin de Argila (1995) High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet 346, 310

130S. Renvert (2006) Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. Journal of Periodontology 77, 11101119

131M. Zaremba (2007) Evaluation of the incidence of periodontitis-associated bacteria in the atherosclerotic plaque of coronary blood vessels. Journal of Periodontology 78, 322327

132B. Chiu (1999) Multiple infections in carotid atherosclerotic plaques. American Heart Journal 138, S534S536

133V.I. Haraszthy (2000) Identification of periodontal pathogens in atheromatous plaques. Journal of Periodontology 71, 15541560

134M. Rassu (2001) Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 158, 7379

135R.J. Martin (2006) Infections and asthma. Clinics in Chest Medicine 27, 8798

136A.L. MacDowell and L.B. Bacharier (2005) Infectious triggers of asthma. Immunology and Allergy Clinics of North America 25, 4566

138R.J. Marttila (1977) Viral antibodies in the sera from patients with Parkinson disease. European Neurology 15, 2533

139R. Rott (1985) Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228, 755756

142M. Salvatore (1997) Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Lancet 349, 18131814

143D. Langford and E. Masliah (2003) The emerging role of infectious pathogens in neurodegenerative diseases. Experimental Neurology 184, 553555

144B.J. Balin (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Medical Microbiology and Immunology 187, 2342

146J. Miklossy (1993) Alzheimer's disease – a spirochetosis? Neuroreport 4, 841848

147G.R. Riviere , K.H. Riviere and K.S. Smith (2002) Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiology and Immunology 17, 113118

150G.A. Jamieson (1991) Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. Journal of Medical Virology 33, 224227

152J.M. Olichney (2000) Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Archives of Neurology 57, 869874

153J.A. Luchsinger (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545551

154T. Voisin (2003) Vascular risk factors and Alzheimer's disease. La Revue de Medecine Interne 24 (Suppl), 288291

155A. Ott (1996) Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39, 13921397

157B.L. Pihlstrom , B.S. Michalowicz and N.W. Johnson (2005) Periodontal diseases. Lancet 366, 18091820

158F.C. Gibson III (2004) Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109, 28012806

159K.J. Mattila , P.J. Pussinen and S. Paju (2005) Dental infections and cardiovascular diseases: a review. Journal of Periodontology 76 (Suppl), 20852088

160B. Seppaa and J. Ainamo (1996) Dark field microscopy of the subgingival microflora in insulin-dependent diabetics. Journal of Clinical Periodontology 23, 6367

161L.J. Ling (2004) Association between human herpesviruses and the severity of periodontitis. Journal of Periodontology 75, 14791485

163N.M. O'Brien-Simpson (2004) Antigens of bacteria associated with periodontitis. Periodontology 2000 35, 101134

164T.J. DeGraba (2004) Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation. Stroke 35 (Suppl 1), 27122719

165H. Kolb and T. Mandrup-Poulsen (2005) An immune origin of type 2 diabetes? Diabetologia 48, 10381050

166F.E. Dewhirst (2000) The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiology and Immunology 15, 196202

169A.S. Mikosza (2001) Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia. Journal of Clinical Microbiology 39, 347350

170W. Burgdorfer (1982) Lyme disease-a tick-borne spirochetosis? Science 216, 13171319

171E.C. Chan (1996) Characterization of a 4.2-kb plasmid isolated from periodontopathic spirochetes. Oral Microbiology and Immunology 11, 365368

173S. Peters (1999) Adherence to and penetration through cells by oral treponemes. Oral Microbiology and Immunology 14, 379383

174C. Wyss (2004) Treponema putidum sp. nov., a medium-sized proteolytic spirochaete isolated from lesions of human periodontitis and acute necrotizing ulcerative gingivitis. International Journal of Systematic and Evolutionary Microbiology 54, 11171122

175J. Miklossy (2008) Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. Journal of Neuroinflammation 5, 40

178A.B. MacDonald and J.M. Miranda (1987) Concurrent neocortical borreliosis and Alzheimer's disease. Human Pathology 18, 759761

179L. Meer-Scherrer (2006) Lyme disease associated with Alzheimer's disease. Current Microbiology 52, 330332

180M. Gutacker (1998) Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Research in Microbiology 149, 3135

181A.R. Marques (2000) Lack of evidence of Borrelia involvement in Alzheimer's disease. Journal of Infectious Diseases 182, 10061007

182A. Galbussera (2008) Lack of evidence for Borrelia burgdorferi seropositivity in Alzheimer disease. Alzheimer Disease and Associated Disorder 22, 308

183A.B. MacDonald (2006) Transfection “Junk” DNA – a link to the pathogenesis of Alzheimer's disease? Medical Hypotheses 66, 11401141

184A.B. MacDonald (2006) Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. Medical Hypotheses. 67, 592600

185M.A. Pappolla (1989) Concurrent neuroborreliosis and Alzheimer's disease: analysis of the evidence. Human Pathology 20, 753757

186J. Miklossy (1994) The spirochetal etiology of Alzheimer's disease: A putative therapeutic approach. In Alzheimer Disease: Therapeutic Strategies. Proceedings of the Third International Springfield Alzheimer Symposium (E. Giacobini and R. Becker , eds), Part I, pp. 4148, Birkhauser, Boston

187J. Miklossy (1994) Further morphological evidence for a spirochetal etiology of Alzheimer's Disease. NeuroReport 5, 12011204

190L. Hesse (2003) Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity. Journal of Bacteriology 185, 65076512

191A.J. McCoy (2006) L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine. Proceedings of the National Academy of Sciences of the United States of America 103, 1790917914

192R. McLaughlin (1999) Alzheimer's disease may not be a spirochetosis. Neuroreport 10, 14891491

194A.B. MacDonald (1986) Borrelia in the brains of patients dying with dementia. Journal of the American Medical Association 256, 21952196

199A.B. MacDonald (1988) Concurrent neocortical borreliosis and Alzheimer's Disease. Annals of the New York Academy of Sciences 539, 468470

200H.C. Gérard (2005) The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microbial Pathogenesis 39, 1926

201H.C. Gérard (2006) Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunology and Medical Microbiology 48, 355366

202B. Paradowski (2007) Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia. Journal of Neurology 254, 154159

203D.M. Appelt (2008) Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae. BMC Neuroscience 9, 13

205H.H. Kornhuber (1996) Propionibacterium acnes in the cortex of patients with Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience 246, 108109

207A.P. Hudson (2000) Chlamydia pneumoniae, APOE genotype, and Alzheimer's disease. In Chlamydial Basis of Chronic Diseases (L. Dolmer , ed.), pp. 121–36, Robert Koch Institute, Springer Verlag, New York

209I. Brook (2008) Microbiology and management of joint and bone infections due to anaerobic bacteria. Journal of Orthopaedic Science 13, 160169

210K. Honjo , R. van Reekum and N.P. Verhoeff (2009) Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimer's Dementia 5, 348360

211A. MacIntyre (2003) Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. Journal of Neuroscience Research 71, 740750

212N.M. Albert (2000) Inflammation and infection in acute coronary syndrome. Journal of Cardiovascular Nursing 15, 1326

214U. Dreses-Werringloer (2006) Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. American Journal of the Medical Sciences 332, 168174

215U. Dreses-Werringloer (2009) Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. International Journal of Medical Microbiology 299, 187201

216D. Nochlin (1999) Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology 53, 1888

218D. Preza (2008) Bacterial profiles of root caries in elderly patients. Journal of Clinical Microbiology 46, 20152021

221J. Howard and G.J. Pilkington (1992) Fibronectin staining detects micro-organisms in aged and Alzheimer's disease brain. Neuroreport 3, 615618

224M. Malaguarnera (2004) Helicobacter pylori and Alzheimer's disease: a possible link. European Journal of Internal Medicine 15, 381386

225J. Kountouras (2006) Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66, 938940

226J. Kountouras (2009) Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. International Journal of Neuroscience 119, 765777

227J. Kountouras (2007) Association between Helicobacter pylori infection and mild cognitive impairment. European Journal of Neurology 14, 976982

228G.A. Jamieson (1992) Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. Journal of Pathology 167, 365368

230F. Xu (2006) Trends in Herpes simplex virus type 1 and type 2 seroprevalence in the United States. Journal of the American Medical Association 296, 964973

234B.G. Pogo , J. Casals and T.S. Elizan (1987) A study of viral genomes and antigens in brains of patients with Alzheimer's disease. Brain 110, 907915

235D.G. Walker , J.R. O'Kusky and P.L. McGeer (1989) In situ hybridization analysis for herpes simplex virus nucleic acids in Alzheimer disease. Alzheimer Disease and Associated Disorder 3, 123131

() . , –236R.F. Itzhaki 1997 Herpes simplex virus type 1 in brain and risk of Alzheimer's disease Lancet 349 241244

237S. Itabashi (1997) Herpes simplex virus and risk of Alzheimer's disease. Lancet 349, 1102

239U. Beffert (1998) HSV-1 in brain and risk of Alzheimer's disease. Lancet 351, 13301331

241M.A. Wozniak , A.P. Mee and R.F. Itzhaki (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. Journal of Pathology 217, 131138

242M.A. Wozniak (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. Journal of Medical Virology 75, 300306

243E.B. Renvoize , I.O. Awad and M.H. Hambling (1987) A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age and Ageing 16, 311314

244A. Ounanian (1990) Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer's disease. Journal of Clinical Laboratory Analysis 4, 367375

245L. Letenneur (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 3, 3637

246W.R. Lin (2002) Herpesviruses in brain and Alzheimer's disease. Journal of Pathology 197, 395402

248A. Aiello (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatrics Society 54, 10461054

249T. Matsuse (1994) Immunohistochemical and in situ hybridisation detection of adenovirus early region 1A (E1A) gene in the microglia of human brain tissue. Journal of Clinical Pathology 47, 275277

250T. Igata (1997) Dementia and Borna disease virus. Dementia and Geriatric Cognitive Disorders 9, 2425

252R.M. Chalmers , D.R. Thomas and R.L. Salmon (2005) Borna disease virus and the evidence for human pathogenicity: a systematic review. QJM 98, 255274

253T. Stahl (2006) Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice. European Journal of Neuroscience 24, 19231934

254H.C. Rempel and L. Pulliam (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS (London, England) 19, 127135

255W. Lang (1989) Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathologica 77, 379390

256E.W. Hook III (1989) Syphilis and HIV infection. Journal of Infectious Diseases 160, 530534

257U.V. Comandini (1997) Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus. European Journal of Clinical Microbiology and Infectious Diseases 16, 720726

258A.A. Tobian and T.C. Quinn (2009) Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Current Opinion in HIV and AIDS 4, 294299

259J.S. Burgos (2006) Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. Journal of Virology 80, 53835387

260R.M. Miller and H.J. Federoff (2008) Isoform-specific effects of ApoE on HSV immediate early gene expression and establishment of latency. Neurobiology of Aging 29, 7177

261J. Miklossy (2006) Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiology of Aging 27, 228236

262C.S. Little (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiology of Aging 25, 419429

264D.H. Cribbs (2000) Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's Aβ peptide. Biochemistry 39, 59885994

265P. Satpute-Krishnan , J.A. DeGiorgis and E.L. Bearer (2003) Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer's disease. Aging Cell 2, 305318

266M.A. Wozniak (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neuroscience Letters 429, 95100

270I. Boggian (2000) Asymptomatic herpes simplex type 1 virus infection of the mouse brain. Journal of Neurovirology 6, 303313

271T. Valyi-Nagy (2000) Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology 278, 309321

272A. Fox (1990) Role of bacterial debris in inflammatory diseases of the joint and eye. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 98, 957968

275N. Palaniyar (2002) Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands. Immunobiology 205, 575594

276M.F. Gebbink (2005) Amyloids–a functional coat for microorganisms. Nature Reviews. Microbiology 3, 333341

278U. Gophna (2001) Curli fibers mediate internalization of Escherichia coli by eukaryotic cells. Infection and Immunity 69, 26592665

279A. Ben Nasr (1996) Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Molecular Microbiology 20, 927935

280A. Olsén , A. Jonsson and S. Normark (1989) Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature 338, 652655

281U. Sjöbring , G. Pohl and A. Olsén (1994) Plasminogen, absorbed by Escherichia coli expressing curli or by Salmonella enteritidis expressing thin aggregative fimbriae, can be activated by simultaneously captured tissue-type plasminogen activator (t-PA). Molecular Microbiology 14, 443445

282M. Hammar (1995) Expression of two csg operons is required for production of fibronectin- and congo red-binding curli polymers in Escherichia coli K-12. Molecular Microbiology 18, 661670

283T. Umemoto , M. Li and I. Namikawa (1997) Adherence of human oral spirochetes by collagen-binding proteins. Microbiology and Immunology 41, 917923

284P.J. Crack and P.J. Bray (2007) Toll-like receptors in the brain and their potential roles in neuropathology. Immunology and Cell Biology 85, 476480

285E. Lorenz (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Archives of Internal Medicine 162, 10281032

286S. Kiechl , C.J. Wiedermann and J. Willeit (2003) Toll-like receptor 4 and atherogenesis. Annals of Medicine 35, 164171

287S. Akira and K. Takeda (2004) Functions of toll-like receptors: lessons from KO mice. Comptes Rendus Biologies 327, 581589

288P. Tobias and L.K. Curtiss (2005) Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. Journal of Lipid Research 46, 404411

289S.E. Turvey and T.R. Hawn (2006) Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clinical Immunology 120, 19

292N.W. Schroeder (2004) Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. Journal of Immunology 173, 26832691

294G. Ramesh (2003) Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. European Journal of Immunology 33, 25392550

297F.G.E. Van der Goot (2001) Pore Forming Toxins. Springer Verlag, Berlin

298N.O. Gekara (2007) The multiple mechanisms of Ca(2+) signalling by listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes. Cellular Microbiology 9, 20082021

299M.R. Gonzalez (2008) Bacterial pore-forming toxins: The (w)hole story ? Cellular and Molecular Life Sciences 65, 493507

300N.O. Gekara and S. Weiss (2004) Lipid rafts clustering and signalling by listeriolysin O. Biochemical Society Transactions 32, 712714

301P. Cossart and M. Lecuit (1998) Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. EMBO Journal 17, 37973806

302S. Kayal (1999) Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines. Molecular Microbiology 31, 17091722

303M.A. Hamon (2007) Histone modifications induced by a family of bacterial toxins. Proceedings of the National Academy of Sciences of the United States of America 104, 1346713472

304M.E. Pipkin and J. Lieberman (2007) Delivering the kiss of death: Progress on understanding how perforin works. Current Opinion in Immunology 19, 301308

306M.B. Lawrenz (2003) Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infection and Immunity 71, 44324440

307P. Kraiczy (2001) Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. International Immunopharmacology 1, 393401

308L.C. Stanley (1994) Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 53, 231238

309N.A. Brabers and H.S. Nottet (2006) Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. European Journal of Clinical Investigation 36, 447458

310J.G. Sheng (1996) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiology of Aging 17, 761766

311D. Goldgaber (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 86, 76067610

312S.W. Barger (2008) Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies. Journal of Neuropathology and Experimental Neurology 67, 773783

314J.G. Sheng (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Experimental Neurology 163, 388391

315J.G. Sheng (2001) Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochemistry International 39, 341348

317S.G. Zhu (1999) Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 58, 582587

318Y. Li (2004) Microglial activation by uptake of fDNA via a scavenger receptor. Journal of Neuroimmunology 147, 5055

319S.W. Barger and A.D. Harmon (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878881

320K. Tahara (2006) Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129, 30063019

321H. Scholtzova (2009) Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. Journal of Neuroscience 29, 18461854

322P. Kraiczy and R. Würzner (2006) Complement escape of human pathogenic bacteria by acquisition of complement regulators. Molecular Immunology 43, 3144

323M. Pausa (2003) Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. Journal of Immunology 170, 32143222

324A. Rasley , J. Anguita and I. Marriott (2002) Borrelia burgdorferi induces inflammatory mediator production by murine microglia. Journal of Neuroimmunology 130, 2231

325B. Hauss-Wegrzyniak , P.D. Vraniak and G.L. Wenk (2000) LPS-induced neuroinflammatory effects do not recover with time. Neuroreport 11, 17591763

326T.J. Lehman (1983) Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension. Arthritis and Rheumatism 26, 12591265

327L. Johannsen (1993) Biological properties of bacterial peptidoglycan. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 101, 337344

329L.N. Heiss (1994) Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proceedings of the National Academy of Sciences 91, 267270

331E. Griffiths (1991) Iron and bacterial virulence - a brief overview. Biological Methods 4, 713

332E.D. Weinberg (1992) Iron depletion: a defense against intracellular infection and neoplasia. Life Sciences 50, 12891297

333W.J. Griffiths (2000) Localization of iron transport and regulatory proteins in human cells. QJM 93, 575587

334L. Goodman (1953) Alzheimer's disease; a clinico-pathologic analysis of twenty- three cases with a theory on pathogenesis. Journal of Nervous and Mental Disease 118, 97130

335G.M. Bishop (2002) Iron: a pathological mediator of Alzheimer disease? Developmental Neuroscience 24, 184187

336L.M. Miller (2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. Journal of Structural Biology 155, 3037

337P. Lirk , G. Hoffmann and J. Rieder (2002) Inducible nitric oxide synthase – time for reappraisal. Curr Drug Targets – Inflammation and Allergy 1, 89108

338E.D. Chan , J. Chan and N.W. Schluger (2001) What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. American Journal of Respiratory Cell and Molecular Biology 25, 606612

339D. Chakravortty and M. Hensel (2003) Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes and Infection 5, 621627

340M.U. Shiloh and C.F. Nathan (2000) Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Current Opinion in Microbiology 3, 3542

341C. Bogdan (2001) Nitric oxide and the immune response. Nature Immunology 2, 907916

342S. Ohnishi , A. Koide and S. Koide (2001) The roles of turn formation and cross- strand interactions in fibrillization of peptides derived from the OspA single-layer beta-sheet. Protein Science 10, 20832092

343D. Otzen and P.H. Nielsen (2008) We find them here, we find them there: functional bacterial amyloid. Cellular and Molecular Life Sciences 65, 910927

344M.R. Chapman (2002) Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851855

345P. Larsen (2007) Amyloid adhesins are abundant in natural biofilms. Environmental Microbiology 9, 30773090

346P.B. Jordal (2009) Widespread abundance of functional bacterial amyloid in Mycolata and other Gram-positive bacteria. Applied and Environmental Microbiology 75, 41014110

347X. Wang , N.D. Hammer and M.R. Chapman (2008) The molecular basis of functional bacterial amyloid polymerization and nucleation. Journal of Biological Chemistry 283, 2153021539

349B. Hauss-Wegrzyniak and G.L. Wenk (2002) Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neuroscience Letters 322, 7578

350J. Miklossy (2010) Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging. 31:15031515

351M. Kitazawa (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. Journal of Neuroscience 25, 88438853

352J.C. Knight and D. Kwiatkowski (1999) Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proceedings of the Association of American Physicians 111, 290298

353M.A. Shaw (2001) Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes and Immunity 2, 196204

354S. Roy (1997) Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. Journal of Infectious Diseases 176, 530532

355A. Marangoni (2004) Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunology and Medical Microbiology 40, 187191

356A.C. Steere , E. Dwyer and R. Winchester (1990) Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. New England Journal of Medicine 323, 21923

358J.S. Collins (2000) Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. American Journal of Medical Genetics 96, 823830

359S.M. McCusker (2001) Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 357, 436439

360A. Gnjec (2008) Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. Journal of Neuroinflammation 5, 36

362C. Ballerini (1999) HLA A2 allele is associated with age at onset of Alzheimer's disease. Annals of Neurology 45, 397400

363W.S. Griffin (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. Journal of Neuropathology and Experimental Neurology 54, 276281

364J.A. Nicoll (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Annals of Neurology 47, 365368

365P. Minoretti (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neuroscience Letters 391, 147149

366C.R. Balistreri (2008) Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Current Pharmaceutical Design 14, 26722677

368F. Licastro (2007) Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiology of Aging 28, 16371643

369E.H. Corder (1998) HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nature Medicine 4, 11821184

370R.F. Itzhaki (2004) Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiology of Aging 25, 619627

371R.F. Itzhaki and M.A. Wozniak (2006) Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Progress in Lipid Research 45, 7390

372P.S. Bhattacharjee (2008) Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. Experimental Eye Research 87, 122130

373R.F. Itzhaki and M.A. Wozniak (2010) Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimer's Dementia 6, 8384

374V.H. Perry , C. Cunningham and C. Holmes (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nature Reviews. Immunology 7, 161167

375V.H. Perry , J.A. Nicoll and C. Holmes (2010) Microglia in neurodegenerative disease. Nature Reviews. Neurology 6, 193201

376C. Holmes and D. Cotterell (2009) Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 23, 9931002

377A.R. Kamer (2009) TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. Journal of Neuroimmunology 216, 9297

378R. Blatz (2005) Neurosyphilis and neuroborreliosis. Retrospective evaluation of 22 cases. Der Nervenarzt 76, 724732

379D. Bolintineanu (2009) Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides 31, 18

380N. Kobayashi (2008) Binding sites on tau proteins as components for antimicrobial peptides. Biocontrol Science 13, 4956

381S.S. Shaftel (2007) Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. Journal of Clinical Investigation 117, 15951604

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score